Navigation Links
Chem Rx Surpasses 65,000 Residents Served
Date:2/7/2008

- Exhibits Growth In All Existing Markets -

LONG BEACH, N.Y., Feb. 7 /PRNewswire-FirstCall/ -- Chem Rx Corporation (OTC Bulletin Board: PMQC, PMQCU, PMQCW), the third largest long-term care pharmacy, today announced that it has surpassed 65,000 beds served. The Company experienced growth across all four of its institutional pharmacies, which serve a variety of long-term care facilities in the New York City metropolitan area, as well as parts of New Jersey, upstate New York, and Pennsylvania.

"The continued organic growth coupled with consistent revenue growth at all of our pharmacies demonstrates the success of our strategy to increase our market share and revenue in our existing regions," said Steven Silva, President and COO of Chem Rx. "We are pleased with the success that we have seen thus far in terms of creating growth and are also pleased with initial results from a recent SG&A review. We expect to continue these trends in our soon to be opened Deerfield Beach, FL pharmacy."

About Chem Rx

Founded more than 40 years ago, Chem Rx is a major, long-term care pharmacy serving the New York City metropolitan area, as well as parts of New Jersey, upstate New York, and Pennsylvania. Chem Rx's client base includes skilled nursing facilities and a wide range of other long-term care facilities. Chem Rx provides to more than 65,000 residents prescription and non-prescription drugs, intravenous medications, durable medical equipment items and surgical supplies. Chem Rx's website address is http://www.chemrx.net.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about Chem Rx Corporation. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are based upon the current beliefs and expectations of Chem Rx's management and are subject to risks and uncertainties that could cause actual results to differ from the forward- looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: compliance with government regulations; changes in legislation or regulatory environments; requirements or changes adversely affecting the health care industry, including changes in Medicare reimbursement policies; fluctuations in customer demand; management of rapid growth; intensity of competition; timing, approval and market acceptance of new product introductions; general economic conditions; geopolitical events and regulatory changes, as well as other relevant risks detailed in Chem Rx Corporation's filings with the SEC. The information set forth herein should be read in light of such risks. Chem Rx Corporation does not assume any obligation to update the information contained in this press release.

Contacts:

Steven Silva

President and Chief Operating Officer

Chem Rx

investors@chemrx.net

Stephanie Carrington / Elizabeth Scott

The Ruth Group

646-536-7017 / 7014

scarrington@theruthgroup.com

escott@theruthgroup.com


'/>"/>
SOURCE Chem Rx Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ZONARE Surpasses 1000th Worldwide z.one Ultrasound System Shipment
2. Left in the Dark and Facing Thousands in Rent Increases, Elderly Atria Senior Living Residents Protest; Call for Improvements
3. Colorado Residents and Visitors to Investigate Health in a Whole New Way
4. Rural Residents Get Fewer Organ Transplants: Study
5. Highmark to Present States Newest Residents with Healthcare Gift Cards
6. Long Term Care Pharmacy Alliance Expands Membership; Members Now Serve Most of the Nations Nursing Home Residents
7. Overwhelming Majority of Michigan Residents Favors Individual Health Insurance Market Reforms Supported by Blue Cross Blue Shield of Michigan
8. New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves
9. Report to Detail How Manor Care Buyout by The Carlyle Group Could Hamper Care for Florida Nursing Home Residents
10. PA Residents Losing Employer Coverage at Rate Second Only to CA
11. WellPoint Provides Support and Resources to Most Vulnerable California Residents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps ... in Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally ... one hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... search for and donate to Give To Cure’s campaign that is crowdfunding clinical trials ... users make and share payments through a smart device. In 2015 alone, Venmo processed ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Dr. Justin ... announce their 2nd Annual No Cost Dental Day to individuals in need. The event ... purpose of this No Cost Dental Day is to provide dental care to community ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
(Date:2/4/2016)... DIEGO, Feb. 4, 2016  Aethlon Medical, Inc. ... affinity biofiltration devices to treat life-threatening diseases, today ... 2016 ended December 31, 2015. ... objectives set forth in our last quarterly call, ... reinforce our long-term objective to establish the Aethlon ...
Breaking Medicine Technology: